Butterfly Network, Inc. (BFLY)
After hours:
Chart Events
Performance Outlook
| Previous Close | 8.61 |
| Open | 8.35 |
| Bid | 8.60 x 3000 |
| Ask | 8.72 x 2900 |
| Day's Range | 7.45 - 8.65 |
| 52 Week Range | 2.31 - 13.56 |
| Volume | |
| Avg. Volume | 2,397,864 |
| Market Cap | 1.706B |
| Beta (5Y Monthly) | 2.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings Date | Mar 28, 2022 - Apr 01, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
- Zacks
Has AVEO Pharmaceuticals (AVEO) Outpaced Other Medical Stocks This Year?
Here is how AVEO Pharmaceuticals (AVEO) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
- Business Wire
Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action
GUILFORD, Conn. & NEW YORK, August 08, 2022--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981, lacks merit and is mean
- Business Wire
Butterfly Network Reports Second Quarter 2022 Financial Results
GUILFORD, Conn. & NEW YORK, August 03, 2022--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended June 30, 2022, and provided a business update.
